133 related articles for article (PubMed ID: 12529277)
1. Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice.
Schneider A; Zhang Y; Guan Y; Davis LS; Breyer MD
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F411-7. PubMed ID: 12529277
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
Jin C; McKeehan K; Wang F
Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
[TBL] [Abstract][Full Text] [Related]
3. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
Licht AH; Raab S; Hofmann U; Breier G
Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
[TBL] [Abstract][Full Text] [Related]
5. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
Utomo AR; Nikitin AY; Lee WH
Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
[TBL] [Abstract][Full Text] [Related]
6. Podocyte-specific expression of cre recombinase in transgenic mice.
Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
[TBL] [Abstract][Full Text] [Related]
7. Flp recombinase transgenic mice of C57BL/6 strain for conditional gene targeting.
Takeuchi T; Nomura T; Tsujita M; Suzuki M; Fuse T; Mori H; Mishina M
Biochem Biophys Res Commun; 2002 May; 293(3):953-7. PubMed ID: 12051751
[TBL] [Abstract][Full Text] [Related]
8. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium.
el Marjou F; Janssen KP; Chang BH; Li M; Hindie V; Chan L; Louvard D; Chambon P; Metzger D; Robine S
Genesis; 2004 Jul; 39(3):186-93. PubMed ID: 15282745
[TBL] [Abstract][Full Text] [Related]
12. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
[TBL] [Abstract][Full Text] [Related]
13. Thick ascending limb-specific expression of Cre recombinase.
Stricklett PK; Taylor D; Nelson RD; Kohan DE
Am J Physiol Renal Physiol; 2003 Jul; 285(1):F33-9. PubMed ID: 12644440
[TBL] [Abstract][Full Text] [Related]
14. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.
Belteki G; Haigh J; Kabacs N; Haigh K; Sison K; Costantini F; Whitsett J; Quaggin SE; Nagy A
Nucleic Acids Res; 2005 Mar; 33(5):e51. PubMed ID: 15784609
[TBL] [Abstract][Full Text] [Related]
15. Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity.
Kemp R; Ireland H; Clayton E; Houghton C; Howard L; Winton DJ
Nucleic Acids Res; 2004; 32(11):e92. PubMed ID: 15247325
[TBL] [Abstract][Full Text] [Related]
16. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
Dacquin R; Starbuck M; Schinke T; Karsenty G
Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
[TBL] [Abstract][Full Text] [Related]
17. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
[TBL] [Abstract][Full Text] [Related]
18. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
19. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
20. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse.
Schnütgen F; Doerflinger N; Calléja C; Wendling O; Chambon P; Ghyselinck NB
Nat Biotechnol; 2003 May; 21(5):562-5. PubMed ID: 12665802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]